| GC32782-10mM(1mLinDMSO) |
|
1365888-06-7 |
|
0 |
C26H20ClFN2O2 |
|
|
|
| GC32781-50mg |
|
1446182-94-0 |
|
0 |
C29H36N6O4S |
|
|
|
| GC32781-10mg |
|
1446182-94-0 |
|
0 |
C29H36N6O4S |
|
|
|
| GC32781-5mg |
|
1446182-94-0 |
|
0 |
C29H36N6O4S |
|
|
|
| GC32781-2mg |
|
1446182-94-0 |
|
0 |
C29H36N6O4S |
|
|
|
| GC32781-10mM(1mLinDMSO) |
|
1446182-94-0 |
|
0 |
C29H36N6O4S |
|
|
|
| GC32780-100mg |
|
1150701-66-8 |
GSK1940029 (SCD inhibitor 1)
|
0 |
C18H16Cl2N4O2 |
|
|
|
| GC32780-50mg |
|
1150701-66-8 |
GSK1940029 (SCD inhibitor 1)
|
0 |
C18H16Cl2N4O2 |
|
|
|
| GC32780-10mg |
|
1150701-66-8 |
GSK1940029 (SCD inhibitor 1)
|
0 |
C18H16Cl2N4O2 |
|
|
|
| GC32780-5mg |
|
1150701-66-8 |
GSK1940029 (SCD inhibitor 1)
|
0 |
C18H16Cl2N4O2 |
|
|
|
| GC32780-1mg |
|
1150701-66-8 |
GSK1940029 (SCD inhibitor 1)
|
0 |
C18H16Cl2N4O2 |
|
|
|
| GC32780-10mM(1mLinDMSO) |
|
1150701-66-8 |
GSK1940029 (SCD inhibitor 1)
|
0 |
C18H16Cl2N4O2 |
|
|
|
| GC32779-2g |
|
2097938-44-6 |
E3 Ligase Ligand-Linker Conjugates 1
|
0 |
C23H29N3O10 |
|
|
|
| GC32779-1g |
|
2097938-44-6 |
E3 Ligase Ligand-Linker Conjugates 1
|
0 |
C23H29N3O10 |
|
|
|
| GC32779-500mg |
|
2097938-44-6 |
E3 Ligase Ligand-Linker Conjugates 1
|
0 |
C23H29N3O10 |
|
|
|
| GC32779-100mg |
|
2097938-44-6 |
E3 Ligase Ligand-Linker Conjugates 1
|
0 |
C23H29N3O10 |
|
|
|
| GC32778-100mg |
|
1684386-71-7 |
|
0 |
C28H23ClF2N4O4 |
|
|
|
| GC32778-50mg |
|
1684386-71-7 |
|
0 |
C28H23ClF2N4O4 |
|
|
|
| GC32778-10mg |
|
1684386-71-7 |
|
0 |
C28H23ClF2N4O4 |
|
|
|
| GC32778-5mg |
|
1684386-71-7 |
|
0 |
C28H23ClF2N4O4 |
|
|
|
